Friday, 16 April, 2021

Australia probes if blood clot case linked to AstraZeneca vaccine

Australia probes if blood clot case linked to AstraZeneca vaccine Melbourne blood-clotting case 'likely' linked to AstraZeneca vaccine, Deputy CMO says
Ginger Lawrence | 04 April, 2021, 06:51

The UK medical regulator said Saturday that out of 30 people who suffered blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

British regulators have identified 30 cases of rare blood clots after the use of the AstraZeneca Covid-19 vaccine, 25 more than the agency previously reported, after millions of doses were administered.

Dr Fauci provided a dubious answer when asked whether the US Department of Health will use the 300 million doses of AstraZeneca vaccine the US bought previous year.

Up to 24 March, 22 reports of cerebral venous sinus thrombosis (CVST) and eight of other thrombosis events with low platelets were logged.

The World Health Organisation has also urged countries to continue using the jab.

The Netherlands also stopped using the vaccine for a period last month when there were earlier concerns about thrombosis, but started using it again when the European Medicines Agency said the vaccine is both safe and effective.

Amid growing reports of rare blood clots possibly linked to the AstraZeneca shot, the U.K.'s health regulator said the benefits of the shot continue to outweigh the risks. In late March, CSL Ltd began domestic production of 50 million doses.

"It is a complaint "against X", because we have no element against a named person for manslaughter", said Boittin, adding that this "classification can evolve" as the case develops.

Fully vaccinated Americans can resume travel, updated CDC guidance states
Quarantining by fully-vaccinated people after returning to the United States is not necessary unless required by local ordinances. The CDC continues to recommend that those who have not yet been vaccinated do not engage in non-essential travel.

Spain had restricted the vaccine for under-65s, but it reversed its decision, extending the roll-out to those over 65, on Tuesday.

Meanwhile public health experts have said that there is no evidence that the AstraZeneca vaccine is slowing in the United Kingdom despite some European Union nations temporarily pausing its rollout.

The decision to suspend use of the vaccine is a further blow to the Dutch vaccination campaign which is running behind schedule.

On Thursday, Germany's immunisation commission, the STIKO, recommended that anyone younger than 60 who received an initial vaccination with AstraZeneca be given either Pfizer-BioNTech or Moderna shots as their second vaccine doses.

David Werring, a professor at University College London's Institute of Neurology, said that the unusual presentation of the cases in vaccinated people was creating concern about possible links with the shot.

She said: "These kinds of pauses and reviews are a sign that the system is working".

Last week, Britain announced a third coronavirus vaccine from USA firm Moderna (MRNA) will be rolled out in the United Kingdom from April and will join the AstraZeneca and Pfizer (PFE)/ BioNtech (BNTX) jabs already being offered on the NHS.

In November, the United Kingdom became the first Western country to approve a coronavirus vaccine. Almost five million people have gotten their second jab.